Picard Medical showcases leadership in total artificial heart therapy at THT 2026.

Monday, Mar 2, 2026 8:18 am ET1min read
PMI--

Picard Medical, parent company of SynCardia Systems, will showcase leadership in total artificial heart therapy at the Technology and Heart Failure Therapeutics conference. Dr. Andre Simon, Vice President of Clinical Affairs, will present three scientific and educational presentations highlighting additional benefits beyond survival with the SynCardia Total Artificial Heart and preclinical progress for the next-generation Emperor system.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet